iPS Trend


See All

  • 2015.3.23

    On clinical research of treatment for Parkinson's disease
  • 2015.3.13

    iPS cell-based disease modeling for fibrodysplasia ossificans progressiva
  • 2015.3.12

    RepliCel Life Sciences in Japan for Key Industry Meetings
  • 2015.3.5

    New clues on how adult pancreas regenerates
  • 2015.3.4

    New rat model for Parkinson's disease
  • 2015.3.3

    Scaffold-free iPS cell-based hyaline cartilage for joint repair
  • 2015.3.2

    Cyfuse closes 1.4 billion yen Series B funding round to launch overseas sales of bio 3D printer and accelerate development of 3D tissue engineering technology
  • 2015.2.17

    Stemgent, a ReproCELL Group Company and Transposagen Biopharmaceuticals enter into a service partnership agreement providing genetically engineered stem cells
  • 2015.2.16

    iPS cell-derived pancreatic cells can survive and function in mice
  • 2015.2.9

    Cellular Dynamics Manufactures cGMP HLA "Superdonor" Stem Cell Lines to Enable Cell Therapy With Genetic Matching-HLA "Superdonor" Cell Lines Potentially Provide a Beneficial Genetic Match to Large Numbers of Patients-

What's New

  • 2014.10.14

    We renewed our portal site "iPS Trend".


See more

Page top



  • MEXT
  • Japan Science and Technology Agency
Page top